The economics of stone disease

Noah E. Canvasser, Peter Alken, Michael Lipkin, Stephen Y. Nakada, Hiren S. Sodha, Abdulkadir Tepeler, Yair Lotan

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalWorld Journal of Urology
StateAccepted/In press - Jan 20 2017


  • Cost
  • Economics
  • Kidney stones
  • Nephrolithiasis

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'The economics of stone disease'. Together they form a unique fingerprint.

Cite this